RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+17.86%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$345M
AUM Growth
+$345M
(+5.6%)
Cap. Flow
-$27.3M
Cap. Flow
% of AUM
-7.92%
Top 10 Holdings %
Top 10 Hldgs %
30.53%
Holding
110
New
11
Increased
34
Reduced
36
Closed
25
Top Buys
| 1 |
Gilead Sciences
GILD
|
$12.6M |
| 2 |
CELG
Celgene Corp
CELG
|
$11.4M |
| 3 |
Universal Technical Institute
UTI
|
$6.79M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$6.44M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$3.9M |
Top Sells
| 1 |
Universal Health Services
UHS
|
$10.3M |
| 2 |
Alkermes
ALKS
|
$7.2M |
| 3 |
Medtronic
MDT
|
$7.13M |
| 4 |
NPSP
NPS PHARMACEUTICALS INC
NPSP
|
$4.83M |
| 5 |
Incyte
INCY
|
$4.61M |
Sector Composition
| 1 | Healthcare | 80.57% |
| 2 | Consumer Staples | 1.97% |
| 3 | Financials | 1.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
MacroGenics
MGNX
$121M
| $2.63M | 0.76% |
75,000
-10,000
| -12% | -$351K |
|
|
STJ
52
DELISTED
St Jude Medical
STJ
| $2.6M | 0.75% |
40,000
-17,000
| -30% | -$1.11M |
|
53
Ionis Pharmaceuticals
IONS
$9.64B
| $2.59M | 0.75% |
42,000
-16,000
| -28% | -$988K |
|
|
ARRY
54
DELISTED
Array Biopharma Inc
ARRY
| $2.58M | 0.75% |
545,000
+165,801
| +44% | +$784K |
|
|
AMSG
55
DELISTED
Amsurg Corp
AMSG
| $2.57M | 0.75% |
47,000
+4,700
| +11% | +$257K |
|
|
56
Medtronic
MDT
$118B
| $2.53M | 0.73% |
35,000
-98,800
| -74% | -$7.13M |
|
57
Hologic
HOLX
$14.7B
| $2.51M | 0.73% |
94,000
+4,000
| +4% | +$107K |
|
|
AET
58
DELISTED
Aetna Inc
AET
| $2.49M | 0.72% |
28,000
-7,000
| -20% | -$622K |
|
|
CERN
59
DELISTED
Cerner Corp
CERN
| $2.46M | 0.71% |
38,000
-2,000
| -5% | -$129K |
|
60
Edwards Lifesciences
EW
$47.7B
| $2.42M | 0.7% |
114,000
-6,000
| -5% | -$127K |
|
61
Insulet
PODD
$24.2B
| $2.4M | 0.69% |
52,000
-10,911
| -17% | -$503K |
|
|
TSRO
62
DELISTED
TESARO, Inc.
TSRO
| $2.33M | 0.68% |
62,651
+7,651
| +14% | +$285K |
|
63
Old Republic International
ORI
$10B
| $2.32M | 0.67% |
+70,000
| New | +$2.32M |
|
64
Tandem Diabetes Care
TNDM
$834M
| $2.27M | 0.66% |
+17,900
| New | +$2.27M |
|
|
OREX
65
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $2.27M | 0.66% |
37,500
-11,900
| -24% | -$721K |
|
|
PCYC
66
DELISTED
PHARMACYCLICS INC
PCYC
| $2.26M | 0.66% |
18,500
-19,500
| -51% | -$2.38M |
|
67
Alnylam Pharmaceuticals
ALNY
$58.6B
| $2.23M | 0.65% |
23,000
+9,970
| +77% | +$967K |
|
|
CYBX
68
DELISTED
CYBERONICS INC
CYBX
| $2.23M | 0.65% |
40,000
-3,000
| -7% | -$167K |
|
|
RVNC
69
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.14M | 0.62% |
126,574
+21,319
| +20% | +$361K |
|
70
Supernus Pharmaceuticals
SUPN
$2.52B
| $2.08M | 0.6% |
250,800
+38,800
| +18% | +$322K |
|
71
Ligand Pharmaceuticals
LGND
$3.25B
| $2.08M | 0.6% |
62,517
| – | – |
|
72
Dynavax Technologies
DVAX
$1.19B
| $2.07M | 0.6% |
122,835
| – | – |
|
|
KITE
73
DELISTED
Kite Pharma, Inc.
KITE
| $2.02M | 0.58% |
+35,000
| New | +$2.02M |
|
|
OCR
74
DELISTED
OMNICARE INC
OCR
| $1.82M | 0.53% |
25,000
+15,000
| +150% | +$1.09M |
|
75
Myriad Genetics
MYGN
$633M
| $1.7M | 0.49% |
+50,000
| New | +$1.7M |
|